These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17563154)

  • 1. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
    Hofmann SG; Meuret AE; Rosenfield D; Suvak MK; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Consult Clin Psychol; 2007 Jun; 75(3):374-9. PubMed ID: 17563154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
    Barlow DH; Gorman JM; Shear MK; Woods SW
    JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder.
    Hicks TV; Leitenberg H; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Consult Clin Psychol; 2005 Jun; 73(3):506-14. PubMed ID: 15982148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
    Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
    BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.
    Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S
    Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
    Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
    Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-efficacy of individual and combined treatments for panic disorder.
    McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.
    Aaronson CJ; Shear MK; Goetz RR; Allen LB; Barlow DH; White KS; Ray S; Money R; Saksa JR; Woods SW; Gorman JM
    J Clin Psychiatry; 2008 Mar; 69(3):418-24. PubMed ID: 18278989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
    van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
    Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
    Vos SP; Huibers MJ; Diels L; Arntz A
    Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coincidence of schizophrenia and panic disorder].
    Rupprecht R; Ströhle A
    Nervenarzt; 1999 Mar; 70(3):265-8. PubMed ID: 10231815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emotion Regulation Strategies in Cognitive Behavioral Therapy for Panic Disorder.
    Strauss AY; Kivity Y; Huppert JD
    Behav Ther; 2019 May; 50(3):659-671. PubMed ID: 31030881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panic disorder--it's real and it's treatable.
    Glass RM
    JAMA; 2000 May; 283(19):2573-4. PubMed ID: 10815122
    [No Abstract]   [Full Text] [Related]  

  • 15. Discussion of "methodological controversies in the treatment of panic disorder".
    Klein DF
    Behav Res Ther; 1996; 34(11-12):849-53; discussion 855-63. PubMed ID: 8990537
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive mediation of clinical improvement after intensive exposure therapy of agoraphobia and social phobia.
    Vögele C; Ehlers A; Meyer AH; Frank M; Hahlweg K; Margraf J
    Depress Anxiety; 2010 Mar; 27(3):294-301. PubMed ID: 20037922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
    Gelder MG
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):2S-5S. PubMed ID: 9872706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in adult anxious and avoidant attachment during cognitive behavioral therapy for panic disorder.
    Zalaznik D; Weiss M; Huppert JD
    Psychother Res; 2019 Apr; 29(3):337-353. PubMed ID: 28826378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis.
    Smits JA; Powers MB; Cho Y; Telch MJ
    J Consult Clin Psychol; 2004 Aug; 72(4):646-52. PubMed ID: 15301649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.